Catheter Precision (VTAK) Change in Acquisitions & Divestments (2019 - 2020)
Catheter Precision's (VTAK) quarterly Change in Acquisitions & Divestments came in at $5.0 million in Q2 2020, down 54.55% on a QoQ basis from $11.0 million in Q1 2020.
Catheter Precision (VTAK) Change in Acquisitions & Divestments (2019 - 2020) Analysis & Trends
Catheter Precision (VTAK) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $5.0 million in Q2 2020.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $5.0 million in Q2 2020; TTM through Dec 2020 was $16.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $300000.0, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q2 2020 stood at $5.0 million, down from $11.0 million in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for VTAK reached as high as $11.0 million in Q1 2020 and fell as low as $5.0 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.64 Bn | 176.34 Bn | 6.27 Bn |
| 2 | Stryker | 129.04 Bn | 126.16 Bn | 3.81 Bn |
| 3 | Medtronic | 109.04 Bn | 99.82 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.67 Bn | 45.00 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.34 Bn | - |
| 9 | Koninklijke Philips | 25.48 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Catheter Precision | 591,794.39 | 191,794.39 | 390,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 5.00 Mn |
| Jun 30, 2020 | 5.00 Mn |
| Mar 31, 2020 | 11.00 Mn |
| Mar 31, 2020 | 11.00 Mn |
| Dec 31, 2019 | 10.00 Mn |
| Dec 31, 2019 | 10.00 Mn |